Scholarlink

<p>This study aimed to identify factors present at the initial visit for the development of sunset glow fundus (SGF) in Vogt–Koyanagi–Harada (VKH) disease. A total of 139 eyes from 70 naïve patients with acute VKH disease who underwent pulse steroid therapy were categorized into “SGF” and “non-SGF” groups based on fundus appearance at 12 months post-therapy. Multivariable analysis revealed that patients with meningismus (p = 0.004), incomplete type (p = 0.035), and probable type (p = 0.002) in older revised diagnostic criteria; ex-smoker (p = 0.016), and smoker (p = 0.010) status; high logarithmic best-corrected visual acuity (BCVA) (p &lt; 0.001); high spherical equivalent (SE) (p = 0.005); shallow peripheral anterior chamber depth (ACD) (p &lt; 0.001); narrow anterior chamber angle (ACA) (p = 0.015); increased pupil diameter (p &lt; 0.001); and thicker cornea (p = 0.019) were associated with SGF. The optimal cut-off values for predicting SGF were identified as follows: logarithmic BCVA greater than 0.261, SE exceeding − 2.813 D, peripheral ACD less than 2.138&#xa0;mm, ACA less than 40.55 °, pupil diameter exceeding 3.040&#xa0;mm, and corneal thickness exceeding 579.500&#xa0;μm. Patients with VKH disease who exhibit above risk factors require early and careful management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predictive factors at initial visit for sunset glow fundus in Vogt–Koyanagi–Harada disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月7日

查看全文
  • Tetsuya Muto,
  • Masaaki Sakamoto,
  • Shigeki Machida,
  • Shinichiro Imaizumi,
  • Tetsuju Sekiryu

摘要

This study aimed to identify factors present at the initial visit for the development of sunset glow fundus (SGF) in Vogt–Koyanagi–Harada (VKH) disease. A total of 139 eyes from 70 naïve patients with acute VKH disease who underwent pulse steroid therapy were categorized into “SGF” and “non-SGF” groups based on fundus appearance at 12 months post-therapy. Multivariable analysis revealed that patients with meningismus (p = 0.004), incomplete type (p = 0.035), and probable type (p = 0.002) in older revised diagnostic criteria; ex-smoker (p = 0.016), and smoker (p = 0.010) status; high logarithmic best-corrected visual acuity (BCVA) (p < 0.001); high spherical equivalent (SE) (p = 0.005); shallow peripheral anterior chamber depth (ACD) (p < 0.001); narrow anterior chamber angle (ACA) (p = 0.015); increased pupil diameter (p < 0.001); and thicker cornea (p = 0.019) were associated with SGF. The optimal cut-off values for predicting SGF were identified as follows: logarithmic BCVA greater than 0.261, SE exceeding − 2.813 D, peripheral ACD less than 2.138 mm, ACA less than 40.55 °, pupil diameter exceeding 3.040 mm, and corneal thickness exceeding 579.500 μm. Patients with VKH disease who exhibit above risk factors require early and careful management.